Skip to main content
SpringerLink
Log in

Human blymphocytes immortalization by epstein-barr virus in the presence of cyclosporin a

  • Published:
In Vitro Cellular & Developmental Biology Aims and scope Submit manuscript

Summary

A simple method was devised for the establishment of continuous lymphoblastoid, cell lines (LCL). Unfractionated mononuclear cells collected from healthy donors were infected in vitro by Epstein-Barr Virus (EBV) (strain B95-8) under specific, conditions: an immunosuppressive drug, Cyclosporin-A (CS-A, Sandoz), associated with the use of a feeder layer (MRC-5) led to 100% efficiency of LCL establishment. A bank of 400 LCL was set up for completion of genetic studies. Regression and kinetics of virus-induced transformation were monitored and related to donors' EBV immune status. Mean time of LCL establishment and probability of regression among seropositive donors were not linked to any given value titer of antibodies against Viral Capsid Antigen (VCA) or against Epstein-Barr Nuclear Antigen (EBNA). However, when the anti-VCA:anti-EBNA ratio was considered, this parameter, seemed to be linked to the kinetics of transformation but not to the probability of regression. Once LCL are established, large quantities of human cells can be produced. The complete cellular DNA is available so that any part of it can be scrutinized. Moreover, some of the phenotypic characteristics of these B cells be used for a wide range of investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson, M. A.; Gusella, J. F. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 20:856–858; 1984.

    PubMed  CAS  Google Scholar 

  2. Bejarano, M. T.; Masucci, M. G.; Ernberg, I., et al. Effect of cyclosporin A (CS-A) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells. Int. J. Cancer 35: 327–333; 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Berkel, A. I.; Henle, W.; Henle, G., et al. Epstein-Barr virusrelated patterns in ataxia-telangiectasia. Clin. Exp. Immunol. 35: 196–201; 1979.

    PubMed  CAS  Google Scholar 

  4. Bird, A. G.; McLachlan, S. M.; Britton, S. Cyclosporin A promotes spontaneous outgrowthin vitro of Epstein-Barr virus-induced B-cell lines. Nature 289: 300–301; 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Boyum, A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21 (suppl.): 97: 7R; 1968.

    Google Scholar 

  6. Boyum, A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Invest. 21 (suppl.): 97: 77–89; 1968.

    CAS  Google Scholar 

  7. Gaston, J. S. H. Epstein-Barr virus specific cytotoxic T lymphocytes as probes of HLA polymorphisms. Heterogeneity of T-cell restricting determinants associated with the serologically defined HLA-A2 antigen. J. Exp. Med. 158: 280–293; 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Gusella, J. F.; Wexler, N. S.; Conneally, P. M., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234–238; 1983.

    Article  PubMed  CAS  Google Scholar 

  9. Harada, S.; Sakamoto, K.; Seeley, J. K., et al. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects. J. Immunol. 129: 2532–2535; 1982.

    PubMed  CAS  Google Scholar 

  10. Henderson, E.; Miller, G.; Robinson, J., et al. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 76: 152–163; 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Henle, G.; Henle, W. Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol. 91: 1248–1256; 1966.

    PubMed  CAS  Google Scholar 

  12. Jacobs, J. P.; Jones, C. M.; Baille, J. P. Characteristics of a human diploid cell designated MRC-5. Nature 227: 168–170; 1970.

    Article  PubMed  CAS  Google Scholar 

  13. Klein, E.; Massucci, M. G. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes. Springer Semin. Immunopathol. 5: 63–74; 1982.

    PubMed  CAS  Google Scholar 

  14. Lange, B.; Arbetter, J., et al. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease. Int. J. Cancer 22: 521–527; 1978.

    Article  PubMed  CAS  Google Scholar 

  15. Lombard, Y.; Hartmann, D.; Coupin, G., et al. Human B-like lymphoblastoid cell lines obtained by long-term culture of normal spleen leukocytes. Biol. Cell. 50: 295–298; 1984.

    PubMed  CAS  Google Scholar 

  16. Masucci, M. G.; Bejarano, M. T.; Masucci, G., et al. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell. Immunol. 76: 311–321; 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Miller, G.; Ender, J. F.; Lisco, H., et al. Establishment of lines from normal human blood leukocytes by cocultivation with a leukocyte line derived from a leukemic child (34189). Proc. Soc. Exp. Biol. Med. 132: 247–252; 1969.

    PubMed  CAS  Google Scholar 

  18. Miller, G.; Lisco, H.; Kohn, H. I., et al. Establishment of cell lines from normal adult blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody (35810). Proc. Soc. Exp. Biol. Med. 137: 1459–1467; 1971.

    PubMed  CAS  Google Scholar 

  19. Miller, G.; Lipman, M. Relesase of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70: 190–194; 1973.

    Article  PubMed  CAS  Google Scholar 

  20. Misko, I. S.; Moss, D. J.; Pope, J. H. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77: 4247–4250; 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Misko, I. S.; Kane, R. G.; Pope, J. H. Generationin vitro of HLA-restricted EB virus-specific cytotoxic human T cells by autologous lymphoblastoid cell lines: the role of previous EB virus infection and foetal calf serum. Int. J. Cancer 29: 41–48; 1982.

    Article  PubMed  CAS  Google Scholar 

  22. Misko, I. S.; Pope, J. H.; Hutter, R., et al. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int. J. Cancer 33: 239–243; 1984.

    Article  PubMed  CAS  Google Scholar 

  23. Moss, D. J.; Pope, J. H. Assay of the infectivity of Epstein-Barr virus by transformation of human leukocytesin vitro. J. Gen. Virol. 17: 233–236; 1972.

    PubMed  CAS  Google Scholar 

  24. Moss, D. J.; Pope, J. H. E. B. Virus-associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the QIMR-WIL strain of E. B. Virus. Int. J. Cancer 15: 503–511; 1975.

    Article  PubMed  CAS  Google Scholar 

  25. Moss, D. J.; Scott, W.; Pope, J. H. An immunological basis for inhibition of transformation of human lymphocytes by EB virus. Int. J. Cancer 15:503–511; 1975.

    Article  PubMed  CAS  Google Scholar 

  26. Moss, D. J.; Rickinson, A. B.; Pope, J. H. Long-term T-cell mediated immunity to Epstein-Barr virus in man: I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int. J. Cancer 22:662–668; 1978.

    Article  PubMed  CAS  Google Scholar 

  27. Moss, D. J.; Rickinson, A. B.; Pope, J. H. Long-term T-cell mediated immunity to Epstein-Barr virus in man: III Activation of cytotoxic T-cells in, virus infected leukocyte cultures. Int. J. Cancer 23:618–625; 1979.

    Article  PubMed  CAS  Google Scholar 

  28. Nilsson, K.; Klein, G.; Henle, W., et al. The establishment, of lymphoblastoid, lines from adult, and fetal human lymphoid tissues and its dependence of EBV. Int. J. Cancer 8:443–450; 1971.

    PubMed  CAS  Google Scholar 

  29. Pope, J. H. Tranformation by the virusin vitro. In: Epstein, M. A.; Achong, B. G., eds. The Esptein-Barr virus. Berlin: Springer-Verlag 1979:206–223.

    Google Scholar 

  30. Reedman, B. M.; Klein, G. Cellular localization of an EBV-associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int. J. Cancer 11:499–520; 1973.

    Article  PubMed  CAS  Google Scholar 

  31. Rickinson, A. B.; Moss, D. J.; Pope, J. H. Long-term T-cell mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int. J. Cancer 23:610–617; 1979.

    Article  PubMed  CAS  Google Scholar 

  32. Rickinson, A. B.; Wallace, L. E.; Epstien, M. A. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature 283:865–868; 1980.

    Article  PubMed  CAS  Google Scholar 

  33. Rickinson, A. B.; Moss, D. J. Epstein-Barr virus-induced transformation: immunological aspects. In: Klein, G., ed. Advances in vival oncology, vol. 3. New York: Raven Press; 1983:213–238.

    Google Scholar 

  34. Rickinson, A. B. T-cell control of Herpes virus infections: Lessons from the Epstein-Barr virus. Prog. Brain Res. 59:189–199; 1983.

    Article  PubMed  CAS  Google Scholar 

  35. Rickinson, A. B.; Rowe, M.; Hart, I. J., et al. T-cell mediated regression of “spontaneous” and of Epstein-Barr virus-induced B cell transformation in vitro: Studies with cyclosporin-A. Cell. Immunol. 87:646–658; 1984.

    Article  PubMed  CAS  Google Scholar 

  36. Schooley, R. T.; Arbit, D. I.; Henle, W., et al. T-lymphocyte subset interactions in the cell-mediated immune response to Epstein-Barr virus. Cell. Immunol. 86:402–412; 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Ten Napel, C. H. H.; The, T. H.; Van Egten-Bijker, J., et al. Discordance of Epstein-Barr virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titers and lowered in vitro lymphocytes reactivity. Clin. Exp. Immunol. 34:338–346; 1978.

    PubMed  CAS  Google Scholar 

  38. Thorley-Lawson, D. A.; Chess, L.; Strominger, J. L. Suppression ofin-vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J. Exp. Med. 146:495–508; 1977.

    Article  PubMed  CAS  Google Scholar 

  39. White, R.; Leppert, M.; Bishop, D. T., et al. Construction of linkage maps with DNA markers for human chromosomes. Nature 313:101–105; 1985.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon cedex 08, France

    F. Pelloquin & G. M. Lenoir

  2. CNRS-Faculte de Medicine Alexis Carrel, rue Guillaume Paradin, 69372, Lyon cedex 08, France

    J. P. Lamelin

Authors
  1. F. Pelloquin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. P. Lamelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. Lenoir
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The work was supported by Fondation de la Recherche Medicale (France) for Professor J. Dausset (Paris) and by the International Agency for Research on Cancer (Lyon).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pelloquin, F., Lamelin, J.P. & Lenoir, G.M. Human blymphocytes immortalization by epstein-barr virus in the presence of cyclosporin a. In Vitro Cell Dev Biol 22, 689–694 (1986). https://doi.org/10.1007/BF02621085

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02621085

Key words

Search

Navigation